Physician profile

Keith Farley

Optometrist · Mt Pleasant, SC

NPI 1477616647

$1,079.94

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Entertainment$96.89

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Optos, INC. $248.15 2019-2023 Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700
Coopervision INC. $238.33 2020-2022
Alcon Vision LLC $227.56 2019-2020
Shire North American Group INC $123.90 2019
Genentech USA, INC. $116.00 2020
Johnson & Johnson Vision Care, INC. $90.34 2019
Allergan, INC. $35.66 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Keith Farley

$1,079.94

in general payments reported 2019-2025

Years
2019-2023
Top company
Optos, INC.

https://glasscript.com/doctor/157316/keith-farley

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.